Development and preliminary validation of a pain measure specific to neuropathic pain: The neuropathic pain scale

被引:571
作者
Galer, BS
Jensen, MP
机构
[1] UNIV WASHINGTON, SCH MED, DEPT NEUROL, SEATTLE, WA 98105 USA
[2] UNIV WASHINGTON, SCH MED, DEPT ANESTHESIOL, SEATTLE, WA 98105 USA
[3] UNIV WASHINGTON, SCH MED, DEPT REHABIL MED, SEATTLE, WA 98105 USA
关键词
D O I
10.1212/WNL.48.2.332
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuropathic pain syndromes are commonly seen in clinical practice and are frequently used as pain models in testing new therapies. However, no pain scale exists with the primary purpose to measure pain in neuropathic syndromes. This paper describes the development and preliminary validation of the Neuropathic Pain Scale (NPS), which is designed to assess distinct pain qualities associated with neuropathic pain. Results support the discriminant. and predictive validity of the NPS items. Moreover, the NPS items appear to be sensitive to treatments known to impact neuropathic pain. These findings provide support for the further development of the NPS.
引用
收藏
页码:332 / 338
页数:7
相关论文
共 28 条
[1]
[Anonymous], 1987, PAIN
[2]
[Anonymous], HDB PAIN ASSESSMENT
[3]
TRANSDERMAL CLONIDINE COMPARED TO PLACEBO IN PAINFUL DIABETIC NEUROPATHY USING A 2-STAGE ENRICHED ENROLLMENT DESIGN [J].
BYASSMITH, MG ;
MAX, MB ;
MUIR, J ;
KINGMAN, A .
PAIN, 1995, 60 (03) :267-274
[4]
CAMPBELL JN, 1992, APS J, V1, P3
[5]
Chadda V S, 1978, J Assoc Physicians India, V26, P403
[6]
DIABETIC PERIPHERAL NEUROPATHY - NERVE-CONDUCTION STUDIES BEFORE, DURING AND AFTER CARBAMAZEPINE THERAPY [J].
CHAKRABARTI, AK ;
SAMANTARAY, SK .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1976, 6 (06) :565-568
[7]
DEJGARD A, 1988, LANCET, V1, P9
[8]
ELLENBERG M, 1968, NEW YORK STATE J MED, V68, P2653
[9]
FIELDS HL, 1994, PROG PAIN RES MANAG, V2, P437
[10]
RESPONSE TO INTRAVENOUS LIDOCAINE INFUSION DIFFERS BASED ON CLINICAL-DIAGNOSIS AND SITE OF NERVOUS-SYSTEM INJURY [J].
GALER, BS ;
MILLER, KV ;
ROWBOTHAM, MC .
NEUROLOGY, 1993, 43 (06) :1233-1235